Novartis has teamed up with J. Craig Venter's newly formed Synthetic Genomic Vaccines Inc. in an effort to accelerate the "production of seasonal and pandemic flu vaccines," the Wall Street Journal reports. According to Fierce Vaccines, the two firms have agreed to collaborate over a period of three years.